Literature DB >> 20719365

Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men.

Jim C Hu1, Sandip M Prasad, Xiangmei Gu, Stephen B Williams, Stuart R Lipsitz, Paul L Nguyen, Toni K Choueiri, Wesley W Choi, Anthony V D'Amico.   

Abstract

OBJECTIVE: Controversy persists regarding the adequacy of pelvic lymph node dissection (PLND) and cancer control when comparing minimally invasive radical prostatectomy (MIRP) and open radical prostatectomy (RRP). We characterized determinants of performance and extent of PLND during radical prostatectomy in elderly men.
METHODS: A population-based study was conducted comprised of 5448 men ≥65 years undergoing RRP and MIRP during 2004 to 2006 from Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked data. Multivariable logistic regression was used to assess the effect of demographic and tumor characteristics, surgical approach, and surgeon volume on the likelihood of performing PLND.
RESULTS: PLND was performed for 87.6% vs. 38.3% of men undergoing RRP vs. MIRP (P <.001). Among RRP, 82.6% vs. 4.6% underwent extended vs. limited PLND, with a median yield of 4 vs. 3 lymph nodes (P <.001). Median MIRP PLND yield was 3 lymph nodes. In adjusted analyses, men undergoing RRP vs. MIRP (odds ratio [OR] 16.7; 95% confidence interval [CI], 11.1-25.0), those with few vs. multiple comorbidities (OR 1.4, 95% CI 1.02-1.91), intermediate (OR 1.87; 95% CI 1.48-2.37), and high (OR 2.77; 95% CI 2.02-3.78) vs. low-risk features, and men treated by high-volume surgeons (OR 1.008; 95% CI 1.004-1.011) were more likely to undergo PLND. Conversely, Hispanic (OR 0.68, 95% CI 0.49-0.96) vs. white men were less likely to undergo PLND.
CONCLUSIONS: Independent of tumor characteristics, men undergoing RRP vs. MIRP were more likely to undergo PLND with greater lymph node yield and racial variation observed. Further studies are needed to determine the appropriate use of PLND.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20719365     DOI: 10.1016/j.urology.2010.05.015

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Why all prostate cancer surgery should include an adequate lymph node dissection.

Authors:  D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

2.  Suboptimal use of pelvic lymph node dissection: Differences in guideline adherence between robot-assisted and open radical prostatectomy.

Authors:  Jonas Schiffmann; Alessandro Larcher; Maxine Sun; Zhe Tian; Jérémie Berdugo; Ion Leva; Hugues Widmer; Jean-Baptiste Lattouf; Kevin C Zorn; Shahrokh F Shariat; Francesco Montorsi; Markus Graefen; Fred Saad; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2016-08       Impact factor: 1.862

Review 3.  A systematic review of the volume-outcome relationship for radical prostatectomy.

Authors:  Quoc-Dien Trinh; Anders Bjartell; Stephen J Freedland; Brent K Hollenbeck; Jim C Hu; Shahrokh F Shariat; Maxine Sun; Andrew J Vickers
Journal:  Eur Urol       Date:  2013-04-19       Impact factor: 20.096

4.  Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures.

Authors:  Jonathan L Silberstein; Andrew J Vickers; Nicholas E Power; Raul O Parra; Jonathan A Coleman; Rodrigo Pinochet; Karim A Touijer; Peter T Scardino; James A Eastham; Vincent P Laudone
Journal:  J Endourol       Date:  2011-11-08       Impact factor: 2.942

5.  Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.

Authors:  Adrien N Bernstein; Jonathan E Shoag; Ron Golan; Joshua A Halpern; Edward M Schaeffer; Wei-Chun Hsu; Paul L Nguyen; Art Sedrakyan; Ronald C Chen; Scott E Eggener; Jim C Hu
Journal:  J Urol       Date:  2017-12-26       Impact factor: 7.450

6.  Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.

Authors:  Michael A Liss; Kerrin Palazzi; Sean P Stroup; Ramzi Jabaji; Omer A Raheem; Christopher J Kane
Journal:  World J Urol       Date:  2013-03-20       Impact factor: 4.226

7.  Australian patterns of prostate cancer care: Are they evolving?

Authors:  Jonathon Lo; Nathan Papa; Damien M Bolton; Declan Murphy; Nathan Lawrentschuk
Journal:  Prostate Int       Date:  2015-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.